Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Yuji Mano"'
Publikováno v:
ACS Omega, Vol 9, Iss 6, Pp 6797-6802 (2024)
Externí odkaz:
https://doaj.org/article/73fecc04262c474f96522d5a4c82f3c4
Publikováno v:
ACS Omega, Vol 8, Iss 39, Pp 36261-36268 (2023)
Externí odkaz:
https://doaj.org/article/95bbf68833854615b33af03d82e52683
Autor:
Hitoshi Mizuo, Yuji Mano
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Lenvatinib (Lenvima) is a tyrosine kinase inhibitor on the market and has been used for the treatment of various types of cancer. It is important to understand differences in pharmacokinetics (PK) between nonclinical animals and humans, and
Externí odkaz:
https://doaj.org/article/567dc092d1eb4bfd8e29acf179e8c5c7
Autor:
Yuji Mano
Publikováno v:
Practical Laboratory Medicine, Vol 12, Iss , Pp - (2018)
Cross validation studies for bioanalytical methods are important to ensure that assay data from all study sites where sample analysis is performed can be compared throughout clinical trials. To support global clinical studies of lenvatinib, a novel m
Externí odkaz:
https://doaj.org/article/ba7ea6fb92594b1ba4ed1d34ff846b11
Autor:
Yuki Niwa, Keito Adachi, Kimiyo Tabata, Ryoga Ishida, Koichiro Hotta, Tomomi Ishida, Yuji Mano, Yoichi Ozawa, Yukinori Minoshima, Yasuhiro Funahashi, Taro Semba
Publikováno v:
Molecular Cancer Therapeutics. 22:499-510
Eribulin is a microtubule dynamics inhibitor with tumor microenvironment modulation activity such as vascular remodeling activity. Here, we investigated antitumor and immunomodulatory activities of eribulin and its liposomal formulation (eribulin-LF)
Publikováno v:
European Journal of Mass Spectrometry. 28:94-103
Exemestane is one of the aromatase inhibitors and has been used to treat breast cancer by lowering estrogen levels. Accurate quantification of exemestane is important to set an optimal dose, and thus a simple assay for exemestane is developed by ultr
Autor:
Taro Semba, Yasuhiro Funahashi, Yukinori Minoshima, Yoichi Ozawa, Yuji Mano, Tomomi Ishida, Koichiro Hotta, Ryoga Ishida, Kimiyo Tabata, Keito Adachi, Yuki Niwa
Legends for supplementary figures S1-S9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::264dec29b13ea55c67fa07fb6d9ea77c
https://doi.org/10.1158/1535-7163.22551991
https://doi.org/10.1158/1535-7163.22551991
Autor:
Taro Semba, Yasuhiro Funahashi, Yukinori Minoshima, Yoichi Ozawa, Yuji Mano, Tomomi Ishida, Koichiro Hotta, Ryoga Ishida, Kimiyo Tabata, Keito Adachi, Yuki Niwa
Supplementary Materials and Methods not included in the main manuscript
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a7cfececafd25c27cf033b3ee3cbe8
https://doi.org/10.1158/1535-7163.22551982.v1
https://doi.org/10.1158/1535-7163.22551982.v1
Autor:
Taro Semba, Yasuhiro Funahashi, Yukinori Minoshima, Yoichi Ozawa, Yuji Mano, Tomomi Ishida, Koichiro Hotta, Ryoga Ishida, Kimiyo Tabata, Keito Adachi, Yuki Niwa
Eribulin is a microtubule dynamics inhibitor with tumor microenvironment modulation activity such as vascular remodeling activity. Here, we investigated antitumor and immunomodulatory activities of eribulin and its liposomal formulation (eribulin-LF)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::760b8301d12ee8deaba5f9b3880a5632
https://doi.org/10.1158/1535-7163.c.6534813.v1
https://doi.org/10.1158/1535-7163.c.6534813.v1
Autor:
Taro Semba, Yasuhiro Funahashi, Yukinori Minoshima, Yoichi Ozawa, Yuji Mano, Tomomi Ishida, Koichiro Hotta, Ryoga Ishida, Kimiyo Tabata, Keito Adachi, Yuki Niwa
Antibody lists used in the flow cytometric analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59c8d42065fddf9dd943033074009e83
https://doi.org/10.1158/1535-7163.22495287.v1
https://doi.org/10.1158/1535-7163.22495287.v1